BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9846389)

  • 1. Medication compliance in patients with chronic schizophrenia: implications for the community management of mentally disordered offenders.
    Duncan JC; Rogers R
    J Forensic Sci; 1998 Nov; 43(6):1133-7. PubMed ID: 9846389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.
    Löffler W; Kilian R; Toumi M; Angermeyer MC
    Pharmacopsychiatry; 2003 May; 36(3):105-12. PubMed ID: 12806568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial and socio-demographic correlates of medication compliance among people with schizophrenia.
    Tsang HW; Fung KM; Corrigan PW
    J Behav Ther Exp Psychiatry; 2009 Mar; 40(1):3-14. PubMed ID: 18417098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Compliance in the treatment of schizophrenia--project ADHES (the renewed results)].
    Chadzyńska M; Meder J; Tyszkowska M
    Psychiatr Pol; 2008; 42(4):561-70. PubMed ID: 19189600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of partial compliance.
    Marder SR
    J Clin Psychiatry; 2003; 64 Suppl 16():3-9. PubMed ID: 14680412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
    Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
    Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Which factors modify drug-compliance?].
    Albus M; Burkes S; Scherer J
    Psychiatr Prax; 1995 Nov; 22(6):228-30. PubMed ID: 8570752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of patient compliance after switching from conventional neuroleptics to the atypical neuroleptic amisulpride.
    Linden M; Scheel T; Eich FX
    J Psychopharmacol; 2006 Nov; 20(6):815-23. PubMed ID: 16401647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
    Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC
    J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study.
    Yamada K; Watanabe K; Nemoto N; Fujita H; Chikaraishi C; Yamauchi K; Yagi G; Asai M; Kanba S
    Psychiatry Res; 2006 Jan; 141(1):61-9. PubMed ID: 16318875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].
    Misdrahi D; Llorca PM; Lançon C; Bayle FJ
    Encephale; 2002; 28(3 Pt 1):266-72. PubMed ID: 12091789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication adherence failure in schizophrenia: a forensic review of rates, reasons, treatments, and prospects.
    Young JL; Spitz RT; Hillbrand M; Daneri G
    J Am Acad Psychiatry Law; 1999; 27(3):426-44. PubMed ID: 10509942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting medication noncompliance after hospital discharge among patients with schizophrenia.
    Olfson M; Mechanic D; Hansell S; Boyer CA; Walkup J; Weiden PJ
    Psychiatr Serv; 2000 Feb; 51(2):216-22. PubMed ID: 10655006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia.
    Remington G; Kwon J; Collins A; Laporte D; Mann S; Christensen B
    Schizophr Res; 2007 Feb; 90(1-3):229-37. PubMed ID: 17208414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Negative vs. positive therapy expectations and compliance vs. noncompliance].
    Linden M
    Psychiatr Prax; 1987 Jul; 14(4):132-6. PubMed ID: 2887002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Compliance in the treatment of schizophrenia -- results of an expert survey in Saxony and Saxony-Anhalt].
    Giessler A; Born A; Helm H; Puschner B; Becker T
    Psychiatr Prax; 2005 Oct; 32(7):349-57. PubMed ID: 16220419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication and psychotherapy in the treatment of chronic schizophrenia.
    Sarti P; Cournos F
    Psychiatr Clin North Am; 1990 Jun; 13(2):215-28. PubMed ID: 1972273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial compliance with antipsychotic medication is common in patients with schizophrenia.
    Rummel-Kluge C; Schuster T; Peters S; Kissling W
    Aust N Z J Psychiatry; 2008 May; 42(5):382-8. PubMed ID: 18473256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.